Category: Joint ventures/collaborations
-
Fitbit Devices Providing Precision Medicine Data
Wearers of Fitbit activity tracking devices now have the option of sharing their data with a large-scale precision medicine project run by National Institutes of Health.
-
Consortium to Speed Vaccine Production
An alliance of research organizations is designing ways to cut the time needed to develop, test, and manufacture new vaccines to as little as 6 months.
-
Designing Strawberry Varieties for Japanese Farms
An agricultural genomics company in Israel and auto maker Toyota began a joint project to design new varieties of strawberries to grow on Japanese farms
-
Start-up Funds Univ. Medical Cannabis Research
A developer of therapies derived from cannabis is sponsoring a 3-year basic and translational research program, including clinical trials, at Imperial College London.
-
Trial Testing DNA Antibody Vaccine for Zika
A clinical trial is enrolling participants testing a vaccine to prevent Zika infections with synthetic DNA particles designed to produce antibodies against the virus.
-
Tissue Chip, A.I. Companies Partner on Heart Drug Discovery
A developer of chip devices emulating heart tissue and a medical analytics company using artificial intelligence are jointly discovering new drugs to treat aging heart muscles.
-
Inhaled Messenger RNA Developed, Tested
An academic-industry team developed an inhaled form of genetic material in nanoscale particles that enables lab mice to safely produce proteins in their lungs.
-
Toxic Neuro Protein Clearance Company Formed
A new enterprise is being formed to develop a device that clears from the nervous system toxic proteins associated with chronic and debilitating neurological disorders.
-
Chip Device to Test Gut Infections on Space Station
A device with human intestine tissue and cells will be launched into space to test effects of weightlessness on immune functions and bacterial infections in the gastrointestinal tract.
-
Companies to Analyze 40,000 Protein Samples
A partnership between genomic analysis company deCode Genetics and proteomics enterprise SomaLogic plans to analyze protein activity in 40,000 human samples.